Prevalence of anti-neutrophil cytoplasmic antibody-associated vasculitis in the south of France, using the capture-recapture method

Archive ouverte

Rubenstein, Emma | Henneton, Pierrick | Rivière, Sophie | Casanova, Marie-Laure | Broner, Jonathan | Arnaud, Erik | Oziol, Eric | Le Quintrec, Moglie | Moranne, Olivier | Jorgensen, Christian | Combe, Bernard | Bourdin, Arnaud | Fontaine, Christophe | Schiffmann, Aurélie | Fraison, Jean-Baptiste | Hallé, Olivier | Fraisse, Thibaut | Veysseyre, Frederic | Taieb, Guillaume | Aerts, Cécile | Crampette, Louis | Alovisetti, Caroline | Guis, Laurence | Mehlal, Souad | Papinaud, Laurence | Le Quellec, Alain | Guilpain, Philippe | Mahr, Alfred

Edité par CCSD ; Oxford University Press (OUP) -

International audience. Objectives : This study aimed to estimate the prevalence of ANCA-associated vasculitis (AAV), ie granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA), in Southern France in 2018, and evaluate differences among Europeans and non-Europeans. Methods : This population-based, cross-sectional study used four sources (hospitals, community-based physicians, laboratories, National Health Insurance) to identify adults ≥ 15 years diagnosed with GPA, MPA or EGPA, living in Hérault and Gard in 2018. Cases were defined using the ACR/EULAR classification criteria, and if necessary, the European Medicines Agency algorithm. Prevalence estimates were standardised to the world population and capture-recapture analysis was used to assess the comprehensiveness of the estimation. The influence of geographical origin was evaluated. Results : 202 patients were selected, with 86 cases of GPA (42.6%), 85 cases of MPA (42.1%), and 31 cases of EGPA (15.3%). The standardised prevalence estimates per million inhabitants for 2018 were: 103 (95%CI 84 – 125) for AAV, 48 (95%CI 35 – 64) for GPA, 39 (95%CI 28 – 53) for MPA and 16 (95%CI 9 – 26) for EGPA, 36 (95%CI 25 – 50) for anti-PR3 positive AAV, 46 (95%CI 34 – 61) for anti-MPO positive AAV, and 16 (95%CI 9 – 26) for ANCA-negative AAV. The global estimation of comprehensiveness by capture-recapture analysis was 80.5%. The number of AAV cases was higher for non-European residents (P=0.001), particularly for MPA (P<0.0001). Conclusion : We provide a new estimate of AAV prevalence in France and show a higher prevalence of MPA in non-European patients.

Suggestions

Du même auteur

Inflammatory bowel diseases in anti-neutrophil cytoplasmic antibody–associated vasculitides: 11 retrospective cases from the French Vasculitis Study Group

Archive ouverte | Humbert, Sébastien | CCSD

International audience. OBJECTIVE:Coexistence of ANCA-associated vasculitis (AAV) and IBD is a rare condition that is rarely described in the literature. The aim of the study was to describe the main characteristics...

Clinical and microbiological characteristics of the infections in patients treated with rituximab for autoimmune and/or malignant hematological disorders

Archive ouverte | Tudesq, Jean-Jacques | CCSD

International audience. INTRODUCTION: Rituximab is commonly used for the treatment of hematological malignancies and autoimmune diseases. Despite a reputation for good tolerance, case-series and registries reported ...

Mastitis associated with Sjögren’s syndrome: a series of nine cases

Archive ouverte | Goulabchand, Radjiv | CCSD

International audience. Sjögren's syndrome is well known to target exocrine glands, especially lacrimal and salivary glands, which share with mammary glands anatomical, histological, and immunological features. Here...

Chargement des enrichissements...